Cryoport, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Accelerated filer
State of Incorporation
NV
Business Address
112 WESTWOOD PLACE, SUITE 350, BRENTWOOD, TN, 37027
Mailing Address
112 WESTWOOD PLACE, SUITE 350, BRENTWOOD, TN, 37027
Phone
(949) 232-1900
Fiscal Year End
1231
EIN
880313393
Financial Overview
FY2025 FY
$168.66M
Revenue
$78.30M
Net Income
$764.99M
Total Assets
$1.40
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | March 26, 2026 | View on SEC |
| 4 Insider stock transaction report | March 25, 2026 | View on SEC |
| 4 Insider stock transaction report | March 25, 2026 | View on SEC |
| 4 Insider stock transaction report | March 25, 2026 | View on SEC |
| 4 Insider stock transaction report | March 17, 2026 | View on SEC |
| 4 Insider stock transaction report | March 17, 2026 | View on SEC |
| 4 Insider stock transaction report | March 17, 2026 | View on SEC |
| 4 Insider stock transaction report | March 16, 2026 | View on SEC |
| 10-K Annual financial report | March 5, 2026 | View on SEC |
| 8-K Current report of material events | March 3, 2026 | View on SEC |
Annual Reports
10-K
March 5, 2026
- Strategic divestiture of CryoPDP for $35M to focus on high-growth cell and gene therapy (CGT) market.
- Significant reduction in operating loss from $10.0 million in 2024 to $1.5 million in 2025.
Insider Trading
STRONG SELL
5 insiders
9 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.